The development of stereotactic body radiotherapy in the past decade: A global perspective

Simon S. Lo; Ben J. Slotman; Michael Lock; Yasushi Nagata; Matthias Guckenberger; Shankar Siva; Matthew Foote; Daniel Tan; Bin S. Teh; Nina A. Mayr; Eric L. Chang; Robert D. Timmerman; Arjun Sahgal

doi:10.2217/fon.15.220

The development of stereotactic body radiotherapy in the past decade: A global perspective

Simon S. Lo, Ben J. Slotman, Michael Lock, Yasushi Nagata, Matthias Guckenberger, Shankar Siva, Matthew Foote, Daniel Tan, Bin S. Teh, Nina A. Mayr, Eric L. Chang, Robert D. Timmerman, Arjun Sahgal

Research output: Contribution to journal › Review article › peer-review

8 Scopus citations

Abstract

In the past 10 years, there has been an exponential increase in the incorporation of stereotactic body radiotherapy, also known as stereotactic ablative radiotherapy, into the armamentarium against various types of cancer in different settings worldwide. In this article in the 10th year anniversary issue of Future Oncology, representatives from the USA, Canada, Japan, Germany, The Netherlands, Australia and Singapore will provide individual perspectives of the development of stereotactic body radiotherapy in their respective countries.

Original language	English (US)
Pages (from-to)	2721-2733
Number of pages	13
Journal	Future Oncology
Volume	11
Issue number	19
DOIs	https://doi.org/10.2217/fon.15.220
State	Published - Oct 1 2015

Keywords

global
stereotactic body radiotherapy

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.2217/fon.15.220

Cite this

@article{3269b79c3fd74a9795765f6d15901422,

title = "The development of stereotactic body radiotherapy in the past decade: A global perspective",

abstract = "In the past 10 years, there has been an exponential increase in the incorporation of stereotactic body radiotherapy, also known as stereotactic ablative radiotherapy, into the armamentarium against various types of cancer in different settings worldwide. In this article in the 10th year anniversary issue of Future Oncology, representatives from the USA, Canada, Japan, Germany, The Netherlands, Australia and Singapore will provide individual perspectives of the development of stereotactic body radiotherapy in their respective countries.",

keywords = "global, stereotactic body radiotherapy",

author = "Lo, {Simon S.} and Slotman, {Ben J.} and Michael Lock and Yasushi Nagata and Matthias Guckenberger and Shankar Siva and Matthew Foote and Daniel Tan and Teh, {Bin S.} and Mayr, {Nina A.} and Chang, {Eric L.} and Timmerman, {Robert D.} and Arjun Sahgal",

note = "Publisher Copyright: {\textcopyright} 2015 Future Medicine Ltd.",

year = "2015",

month = oct,

day = "1",

doi = "10.2217/fon.15.220",

language = "English (US)",

volume = "11",

pages = "2721--2733",

journal = "Future Oncology",

issn = "1479-6694",

publisher = "Future Medicine Ltd.",

number = "19",

}

TY - JOUR

T1 - The development of stereotactic body radiotherapy in the past decade

T2 - A global perspective

AU - Lo, Simon S.

AU - Slotman, Ben J.

AU - Lock, Michael

AU - Nagata, Yasushi

AU - Guckenberger, Matthias

AU - Siva, Shankar

AU - Foote, Matthew

AU - Tan, Daniel

AU - Teh, Bin S.

AU - Mayr, Nina A.

AU - Chang, Eric L.

AU - Timmerman, Robert D.

AU - Sahgal, Arjun

PY - 2015/10/1

Y1 - 2015/10/1

N2 - In the past 10 years, there has been an exponential increase in the incorporation of stereotactic body radiotherapy, also known as stereotactic ablative radiotherapy, into the armamentarium against various types of cancer in different settings worldwide. In this article in the 10th year anniversary issue of Future Oncology, representatives from the USA, Canada, Japan, Germany, The Netherlands, Australia and Singapore will provide individual perspectives of the development of stereotactic body radiotherapy in their respective countries.

AB - In the past 10 years, there has been an exponential increase in the incorporation of stereotactic body radiotherapy, also known as stereotactic ablative radiotherapy, into the armamentarium against various types of cancer in different settings worldwide. In this article in the 10th year anniversary issue of Future Oncology, representatives from the USA, Canada, Japan, Germany, The Netherlands, Australia and Singapore will provide individual perspectives of the development of stereotactic body radiotherapy in their respective countries.

KW - global

KW - stereotactic body radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=84943769445&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943769445&partnerID=8YFLogxK

U2 - 10.2217/fon.15.220

DO - 10.2217/fon.15.220

M3 - Review article

C2 - 26338676

AN - SCOPUS:84943769445

SN - 1479-6694

VL - 11

SP - 2721

EP - 2733

JO - Future Oncology

JF - Future Oncology

IS - 19

ER -

The development of stereotactic body radiotherapy in the past decade: A global perspective

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this